LeMaitre Vascular, Inc.

NASDAQ:LMAT

Medical - Instruments & Supplies

Healthcare
$75.58 +1.74%

+$1.60 today

Market cap
$1.73B
Beta
0.52
P/E (TTM)
34.3
EPS (TTM)
$2.74
Dividend yield
0.96%
52W Low $79.01High $118.01

Volume 0.22M

Average 0.26M

LMAT Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

LeMaitre Vascular, Inc.NASDAQ: LMAT

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue dips below year-ago levels

Q1 FY2026 cost of revenue of $18.16M fell 1.6% year over year, behind the +0.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 0.6% from the prior quarter. Over 3 fiscal years it compounded at +7.8% a year.

Context

  • Cost of revenue amounted to 28.5% of revenue in FY2025, down 2.9 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.6% toward the trailing-twelve-month pace of +0.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.16M-0.6% QoQ
Last fiscal yearDec 2025
$71.06M+3.0% YoY
LTMMar 2026
$70.77M+0.2% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.6%——
1 year+3.0%——
3-year CAGR+7.8%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
71.06M USD
Year-over-year change
+3.0%
4-year CAGR
+7.6%

Cost of Revenue vs competitors

How LMAT compares with its peers on the latest reported figures

  • LMAT's LTM Mar 2026 cost of revenue of $70.77M is the lowest of the 8 companies compared; the peer median is $815.11M.
  • Its year-over-year change of +0.2% is the 5th highest of 8, against a peer median of +7.2%.
  • Cost of revenue amounts to 27.6% of revenue for LMAT, versus a peer median of 37.1%.
LMAT Competitors Peer median
Cost of Revenue for LMAT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$12.51B +0.0%+5.9%33.3%
BSXBoston Scientific CorporationLTM Jun 2026$6.06B -11.0%+7.8%28.8%
TFXTeleflex IncorporatedLTM Jun 2026$1.2B -11.0%-11.5%46.2%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$815.11M +7.2%+7.2%50.6%
PENPenumbra, Inc.LTM Jun 2026$483.98M +12.8%+13.9%32.2%
AORTArtivion, Inc.LTM Mar 2026$169.99M +20.8%+15.4%37.1%
ANGOAngioDynamics, Inc.LTM Feb 2026$146.03M +12.9%-3.6%46.5%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$70.77M +0.2%+7.8%27.6%
Peer median (excluding LMAT) $815.11M+7.2%+7.2%37.1%

Competitors are the stored peer set for LMAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue154.42M161.65M193.48M219.86M249.6M
Cost of Revenue53.04M56.76M66.44M68.96M71.06M
Gross Profit101.38M104.9M127.05M150.9M178.54M
Gross Margin65.7%64.9%65.7%68.6%71.5%
Research & Development11.8M13.29M16.97M15.65M14.14M
Selling, General & Admin53.16M61.67M72.89M83M96.49M
Operating Expenses64.96M78.07M90.34M98.65M110.63M
Depreciation & Amortization9.48M9.43M9.52M9.67M10.42M
EBITDA45.98M36.92M48.99M66.75M90.79M
EBITDA Margin29.8%22.8%25.3%30.4%36.4%
Operating Income36.43M26.83M36.71M52.26M67.91M
Operating Margin23.6%16.6%19.0%23.8%27.2%
Interest Income197K986K3.08M4.95M13.09M
Interest Expense2.22M00205K5.18M
Other Income / Expenses(2.14M)661K2.76M4.62M7.27M
Income Before Tax34.29M27.49M39.48M56.88M75.18M
Pre-Tax Margin22.2%17.0%20.4%25.9%30.1%
Income Tax Expense7.38M6.85M9.37M12.84M17.45M
Net Income26.91M20.64M30.11M44.04M57.73M
Net Margin17.4%12.8%15.6%20.0%23.1%
EPS (Basic)1.270.941.361.962.55
EPS (Diluted)1.250.931.341.932.52
Weighted Avg Shares21.16M21.98M22.22M22.45M22.64M
Weighted Avg Shares (Diluted)21.48M22.17M22.42M22.78M22.93M

LeMaitre Vascular, Inc.

NASDAQ:LMAT

Intrinsic Alpha fair value

Locked

Current Price

$75.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.